BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,539,000 | +4.4% | 19,961 | 0.0% | 0.16% | -9.6% |
Q2 2018 | $1,474,000 | +13.6% | 19,961 | 0.0% | 0.18% | +9.3% |
Q1 2018 | $1,298,000 | +0.6% | 19,961 | 0.0% | 0.16% | +27.6% |
Q4 2017 | $1,290,000 | -36.0% | 19,961 | -37.8% | 0.13% | -29.4% |
Q3 2017 | $2,015,000 | +3.7% | 32,106 | 0.0% | 0.18% | +1.7% |
Q2 2017 | $1,944,000 | +16.8% | 32,106 | 0.0% | 0.18% | +17.2% |
Q1 2017 | $1,665,000 | +16.9% | 32,106 | 0.0% | 0.15% | +18.9% |
Q4 2016 | $1,424,000 | -6.8% | 32,106 | 0.0% | 0.13% | -11.8% |
Q3 2016 | $1,528,000 | +5.2% | 32,106 | 0.0% | 0.14% | +2.1% |
Q2 2016 | $1,452,000 | +6.1% | 32,106 | -3.6% | 0.14% | +8.5% |
Q1 2016 | $1,368,000 | +7.6% | 33,311 | 0.0% | 0.13% | +12.1% |
Q4 2015 | $1,271,000 | +16.2% | 33,311 | 0.0% | 0.12% | +11.5% |
Q3 2015 | $1,094,000 | -53.0% | 33,311 | 0.0% | 0.10% | -48.3% |
Q2 2015 | $2,329,000 | -21.1% | 33,311 | -22.7% | 0.20% | -16.9% |
Q1 2015 | $2,952,000 | -6.5% | 43,095 | 0.0% | 0.24% | -1.6% |
Q4 2014 | $3,158,000 | +2.1% | 43,095 | 0.0% | 0.25% | -0.4% |
Q3 2014 | $3,093,000 | -0.7% | 43,095 | 0.0% | 0.25% | +0.8% |
Q2 2014 | $3,116,000 | -1.7% | 43,095 | 0.0% | 0.24% | -5.0% |
Q1 2014 | $3,171,000 | +5.8% | 43,095 | 0.0% | 0.26% | +7.1% |
Q4 2013 | $2,997,000 | +5.9% | 43,095 | 0.0% | 0.24% | 0.0% |
Q3 2013 | $2,831,000 | -33.9% | 43,095 | -30.3% | 0.24% | -35.6% |
Q2 2013 | $4,281,000 | – | 61,806 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |